The organ transplant immunosuppressant drug market is anticipated to grow at a CAGR of more than 14% during the forecast period. Immunosuppressant drugs also known as anti-rejection drugs lower the body's ability to reject a transplanted organ by blocking the effects of the body’s natural defenses. In most of the cases, immunosuppressant drugs that are taken post-transplant include a combination of drugs and approaches based on a patient's condition. Growth in organ transplant surgeries is one of the key factors to drive organ transplant immunosuppressant drug market growth.
(Get 15% Discount on Buying this Report)
Get Report Sample Copy @
https://www.omrglobal.com/request-sample/organ-transplant-immunosuppressant-drugs-market
Moreover, factors such as advancements in tissue engineering practices and continuous evolving organ transplant techniques will significantly aid in the growth of the organ transplant immunosuppressant drugs market. However, the high-cost organ transplantation processes will restraint organ transplant immunosuppressant drug market growth. Besides, strict organ donation and transplant regulation across the globe will also a major challenge for the growth of organ transplant immunosuppressant drugs market.
A Full Report is Available at:
https://www.omrglobal.com/industry-reports/organ-transplant-immunosuppressant-drugs-market

Segmental Outlook

The global organ transplant immunosuppressant drugs market is segmented based on the drug class, transplant organ, and drug type. Based on the drug class, the market is sub-segmented into calcineurin inhibitors, antiproliferative agents, mTOR inhibitors, steroids, and others. Further, based on the transplant organ type, the market is sub-segmented into the heart, kidney, lung, and others. By drug type, the market is bifurcated into generic and branded drugs.


The kidney segment by the transplant organ will be the fastest-growing

The kidney segment is anticipated to grow with a significant CAGR in the organ transplant immunosuppressant drugs market. The growth of the segment is owing to the increasing kidney transplant cases across the globe. The most commonly prescribed drug after the kidney transplant consists of the combination of a calcineurin inhibitor, an antiproliferative agent, and a corticosteroid. Moreover, the cost of the immunosuppressant drugs prescribed after the transplant is also covered in most of the health insurance which in turn will also fuel the segment growth. For instance, in the US, kidney’s immunosuppressant drugs are covered under Medicare Part B for a period of 36 months after the transplant. However, as per the new rules passed in January 2020, this limit has been eliminated.


Regional Outlooks

The global organ transplant immunosuppressant drugs market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to hold the largest market share in the organ transplant immunosuppressant drugs market during the forecast period. The growth of the organ transplant immunosuppressant drugs market in the region is owing to favorable insurance policies, well-established healthcare infrastructure, and high individual spending on healthcare. Medicare covers the transplant and immunosuppressant drugs cost after the transplant is anticipated to drive the organ transplant immunosuppressant drugs market across the region.


Asia-Pacific will augment with the fastest growth rate in the organ transplant immunosuppressant drugs market

Asia-Pacific is anticipated to show the fastest growth rate in the organ transplant immunosuppressant drugs market owing to the increasing awareness regarding organ donation and transplant procedures. Additionally, technological advancements in the healthcare infrastructure across the region are also expected to propel the growth of the organ transplant immunosuppressant drugs market. Moreover, the surge in healthcare spending by the population including middle-income classes will also significantly aid in the growth of the organ transplant immunosuppressant drugs market across the Asia-Pacific region.


Market Players Outlook

The key players of the organ transplant immunosuppressant drugs market include AstellasPharma Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Neovii Pharmaceuticals AG, Novartis AG, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including merger, and acquisition, collaborations with government, funding to the start-ups, and new product launches to stay competitive in the market.


Recent Activities

In January 2020, AstellasPharma Inc. started the manufacturing of Prograf in Japan in its newly built facility as Toyama Technology Center of AstellasPharma Tech Co., Ltd. Prograf is the first-line immunosuppressant for organ transplantation which is currently marketed in more than 100 countries across the globe.
In November 2019, Asahi Kasei Corp. acquired Veloxis Pharmaceuticals for $1.3 billion, a company engaged in the development and sales of immunosuppressive drugs. With the acquisition, Asahi Kasei Corp. will be able to expand its footprints in the global immunosuppressant drug market.
The Report Covers

⦁ Market value data analysis of 2019 and forecast to 2026.
⦁ Annualized market revenues ($ million) for each market segment.
⦁ Country-wise analysis of major geographical regions.
⦁ Key companies operating in the global Organ transplant immunosuppressant drugs market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
⦁ Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
⦁ Analysis of market-entry and market expansion strategies.
⦁ Competitive strategies by identifying ‘who-stands-where’ in the market.

Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @
https://www.omrglobal.com/report-customization/organ-transplant-immunosuppressant-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404